Catalent Pharma Solutions

URI: https://gptkb.org/entity/Catalent_Pharma_Solutions

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:company
gptkbp:acquiredBy	gptkb:Novo_Holdings
gptkbp:CEO	gptkb:Alessandro_Maselli
gptkbp:formerName	gptkb:Cardinal_Health_PTS
gptkbp:founded	2007
gptkbp:foundedBy	Blackstone Group (as spin-off from Cardinal Health)
gptkbp:headquartersLocation	gptkb:Somerset,_New_Jersey,_United_States
https://www.w3.org/2000/01/rdf-schema#label	Catalent Pharma Solutions
gptkbp:industry	gptkb:biotechnology pharmaceuticals
gptkbp:keyPerson	gptkb:Alessandro_Maselli gptkb:John_Chiminski
gptkbp:notableAcquisition	gptkb:Aptuit gptkb:MaSTherCell gptkb:Paragon_Bioservices gptkb:R.P._Scherer gptkb:Accucaps gptkb:Delpharm gptkb:Juniper_Pharmaceuticals
gptkbp:numberOfEmployees	~17,000
gptkbp:numberOfLocations	gptkb:Asia gptkb:Europe gptkb:North_America gptkb:South_America
gptkbp:parentCompany	gptkb:Novo_Holdings
gptkbp:products	biologics gene therapies cell therapies oral drug delivery softgel technologies injectable drug delivery
gptkbp:publiclyTraded	yes
gptkbp:revenue	$4.28 billion (2023)
gptkbp:servesArea	worldwide
gptkbp:services	drug development biologics manufacturing clinical supply services drug delivery technologies
gptkbp:specialty	biologics manufacturing cell therapy manufacturing gene therapy manufacturing oral, injectable, and inhaled drug delivery
gptkbp:stockSymbol	gptkb:CTLT
gptkbp:tradedOn	gptkb:NYSE
gptkbp:website	https://www.catalent.com/
gptkbp:bfsParent	gptkb:Redwood_Bioscience gptkb:Zydis_fast-dissolve_technology
gptkbp:bfsLayer	7